Rebyota Suspension
Product Images NDC 55566-9800

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Rebyota (NDC 55566-9800). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ferring Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Rebyota 01)

The text is a description of a medical administration kit with an administration tube spike, administration set, and a bag containing REBYOTA. The bag is sealed and opaque, and should be thawed before use. There is a pinch and clamp featured on the spike. A disposable underpad is not included, along with a water-soluble lubricant.*

FDA Label Image

Figure 2 (Rebyota 02)

FDA Label Image

Figure 3 (Rebyota 03)

The text is describing an image labeled as "Figure 3". It appears to show a spike port labeled as "iml" along with a 2z Tex() labeled as "01 1" for administration. A bag containing a thawed REBYOTAin is also visible, along with a tube spike. The bag is described as being sealed and opaque.*

FDA Label Image

Figure 4 And Figure 5 (Rebyota 04)

The text provides instructions for two lying positions: resting on the left side with a bent knee and comfortable arms, and assuming a knee-chest position with the left side of the face resting on the surface and the left arm folded comfortably. No additional information is available.*

FDA Label Image

Figure 6 (Rebyota 05)

This text provides instructions for inserting a medical device into the rectum. Specifically, it suggests inserting about 12 centimeters (5 inches) into the rectum. There is no additional information available to provide the context or purpose for this procedure.*

FDA Label Image

Figure 7 And Figure 8 (Rebyota 06)

FDA Label Image

Figure 9 And Figure 10 (Rebyota 07)

FDA Label Image

Principal Display Panel (150 mL Bag Carton)

REBYOTA is a medication used for rectal administration to alter the gut microbiota in patients. It is made up of live microorganisms sourced from qualified human fecal donors and contains a defined amount of polyethylene glycol 2350 in saline as an excipient. This drug must be stored in an ultra-cold freezer at -60°C to -90°C, and once opened, the content should be used with an Administration Set provided in a separate carton. It is produced by Rebiotix, Inc. and manufactured for Ferring Pharmaceuticals in the United States. This information is not intended to be comprehensive; for dosage information and more, see the enclosed prescribing information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.